Retrospective Analysis of Medication Utilization and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis Treated With Nintedanib or Pirfenidone

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease which results in thickening and scarring of the interstitial tissue. As the only 2 Food and Drug Administration (FDA)-approved medications on the market, it is valuable to compare the impact of nintedanib and pirfenidone on c...

Full description

Saved in:
Bibliographic Details
Published in:Clin Med Insights Circ Respir Pulm Med
Main Authors: Ipatova, Anastasia Y, Koerner, Pamela H, Miller, Richard T, Staskon, Francis, Radi, Melanie
Format: Artigo
Language:Inglês
Published: SAGE Publications 2019
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6416683/
https://ncbi.nlm.nih.gov/pubmed/30890862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179548419834922
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items